Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
5
|
pubmed:dateCreated |
1969-12-30
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
0033-3182
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
10
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
296-303
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:4390779-Adult,
pubmed-meshheading:4390779-Amitriptyline,
pubmed-meshheading:4390779-Female,
pubmed-meshheading:4390779-Humans,
pubmed-meshheading:4390779-MMPI,
pubmed-meshheading:4390779-Male,
pubmed-meshheading:4390779-Middle Aged,
pubmed-meshheading:4390779-Perphenazine,
pubmed-meshheading:4390779-Schizophrenia
|
pubmed:articleTitle |
A sequential comparison of amitriptyline, perphenazine and the amitriptyline-perphenazine combination in recently admitted anergic schizophrenics.
|
pubmed:publicationType |
Journal Article,
Comparative Study
|